These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 322082)
61. The clinical significance of asymptomatic bacteriuria in the nonpregnant woman. Asscher AW; Sussman M; Waters WE; Evans JA; Campbell H; Evans KT; Williams JE J Infect Dis; 1969 Jul; 120(1):17-26. PubMed ID: 5803281 [No Abstract] [Full Text] [Related]
62. Nitrofurantoin lung in a child. Rantala H; Kirvelä O; Anttolainen I Lancet; 1979 Oct; 2(8146):799-800. PubMed ID: 90897 [No Abstract] [Full Text] [Related]
63. Pleural effusion: An uncommon manifestation of nitrofurantoin-induced pulmonary injury. Davis JW; Jones LS Respir Med Case Rep; 2016; 19():65-7. PubMed ID: 27625984 [TBL] [Abstract][Full Text] [Related]
65. 1 day of nitrofurantoin was not as effective as 7 days for asymptomatic bacteriuria in pregnancy. Vousden N; Shennan AH Evid Based Med; 2009 Aug; 14(4):113. PubMed ID: 19648429 [No Abstract] [Full Text] [Related]
66. Experience with treatment of covert bacteriuria in 5-year-old Dundee schoolgirls. Savage DC; Wilson ME; McHardy M; Fee WM Arch Dis Child; 1971 Oct; 46(249):738. PubMed ID: 5118080 [No Abstract] [Full Text] [Related]
67. Clinical effectiveness of intramuscular sodium nitrofurantoin against urinary tract infections. Cox CE; O'Connor FJ; Lacy SS J Urol; 1971 Jan; 105(1):113-8. PubMed ID: 5100862 [No Abstract] [Full Text] [Related]
69. Long-term antibiotics for preventing recurrent urinary tract infection in children. Williams G; Craig JC Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001534. PubMed ID: 30932167 [TBL] [Abstract][Full Text] [Related]
70. Continuous antibiotic prophylaxis in the setting of prenatal hydronephrosis and vesicoureteral reflux. Wong NC; Koyle MA; Braga LH Can Urol Assoc J; 2017; 11(1-2Suppl1):S20-S24. PubMed ID: 28265311 [TBL] [Abstract][Full Text] [Related]
71. Probiotics prophylaxis in pyelonephritis infants with normal urinary tracts. Lee SJ; Cha J; Lee JW World J Pediatr; 2016 Nov; 12(4):425-429. PubMed ID: 27059742 [TBL] [Abstract][Full Text] [Related]
72. The current evidence based medical management of vesicoureteral reflux: The Sickkids protocol. Dave S; Khoury AE Indian J Urol; 2007 Oct; 23(4):403-13. PubMed ID: 19718297 [TBL] [Abstract][Full Text] [Related]
73. Antibiotic prophylaxis in pediatric urology. Song SH; Kim KS Indian J Urol; 2008 Apr; 24(2):145-9. PubMed ID: 19468387 [TBL] [Abstract][Full Text] [Related]
74. Antibiotic prophylaxis for children with primary vesicoureteral reflux: where do we stand today? Costers M; Van Damme-Lombaerts R; Levtchenko E; Bogaert G Adv Urol; 2008; 2008():217805. PubMed ID: 18682820 [TBL] [Abstract][Full Text] [Related]
75. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Lee SJ; Shim YH; Cho SJ; Lee JW Pediatr Nephrol; 2007 Sep; 22(9):1315-20. PubMed ID: 17530295 [TBL] [Abstract][Full Text] [Related]
76. May we go on with antibacterial prophylaxis for urinary tract infections? Beetz R Pediatr Nephrol; 2006 Jan; 21(1):5-13. PubMed ID: 16240156 [TBL] [Abstract][Full Text] [Related]
77. Urinary tract infections in children younger than 5 years of age: epidemiology, diagnosis, treatment, outcomes and prevention. Schlager TA Paediatr Drugs; 2001; 3(3):219-27. PubMed ID: 11310718 [TBL] [Abstract][Full Text] [Related]
78. Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. Le Saux N; Pham B; Moher D CMAJ; 2000 Sep; 163(5):523-9. PubMed ID: 11006762 [TBL] [Abstract][Full Text] [Related]